Market Research Logo

Nucleus Replacement Devices - Medical Devices Pipeline Assessment, 2018

Nucleus Replacement Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Nucleus Replacement Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Nucleus Replacement Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nucleus Replacement Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nucleus Replacement Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nucleus Replacement Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Nucleus Replacement Devices Overview
3 Products under Development
3.1 Nucleus Replacement Devices - Pipeline Products by Stage of Development
3.2 Nucleus Replacement Devices - Pipeline Products by Territory
3.3 Nucleus Replacement Devices - Pipeline Products by Regulatory Path
3.4 Nucleus Replacement Devices - Pipeline Products by Estimated Approval Date
3.5 Nucleus Replacement Devices - Ongoing Clinical Trials
4 Nucleus Replacement Devices - Pipeline Products under Development by Companies
4.1 Nucleus Replacement Devices Companies - Pipeline Products by Stage of Development
4.2 Nucleus Replacement Devices - Pipeline Products by Stage of Development
5 Nucleus Replacement Devices Companies and Product Overview
5.1 Arthro Kinetics AG Company Overview
5.2 Chi2Gel Ltd. Company Overview
5.3 Clariance Inc Company Overview
5.4 CryoLife Inc Company Overview
5.5 DePuy Synthes Inc Company Overview
5.6 Gentis Inc Company Overview
5.7 Hydrospine, Inc. Company Overview
5.8 Ortho Regenerative Technologies Inc Company Overview
5.9 Raymedica, LLC Company Overview
5.10 Replication Medical Inc Company Overview
5.11 Spine Wave Inc Company Overview
5.12 Stryker Corp Company Overview
5.13 TranS1 Inc Company Overview
5.14 Vertebral Technologies Inc Company Overview
5.15 Zimmer Biomet Holdings Inc Company Overview
6 Nucleus Replacement Devices - Recent Developments
6.1 Jul 10, 2018: Stryker announces organizational changes
6.2 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection
6.3 Jun 19, 2018: CryoLife Appoints Marna Borgstrom As Board Director
6.4 May 17, 2018: SpinalCyte Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018
6.5 May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection
6.6 May 03, 2018: RTI Surgical Announces First Quarter 2018 Results
6.7 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results
6.8 Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results
6.9 Apr 26, 2018: Stryker reports first quarter 2018 operating results
6.10 Apr 04, 2018: RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection
6.11 Mar 19, 2018: Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations
6.12 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
6.13 Mar 01, 2018: RTI Surgical Announces Fourth Quarter and Full Year 2017 Results
6.14 Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results
6.15 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
6.16 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
6.17 Jan 05, 2018: RTI Surgical Outlines 2018 Guidance and Long-Term Goals
6.18 Dec 27, 2017: SpinalCyte Announces 25th Patent
6.19 Dec 19, 2017: Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
6.20 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
6.21 Nov 02, 2017: RTI Surgical Announces 2017 Third Quarter Results
6.22 Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results
6.23 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results
6.24 Oct 26, 2017: Stryker reports third quarter 2017 results
6.25 Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico
6.26 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors
6.27 Sep 20, 2017: SpinalCyte Announces New Australian Patent
6.28 Sep 18, 2017: RTI Surgical Continues to Augment Leadership Team to Accelerate its Strategic Direction
6.29 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
6.30 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results
6.31 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
6.32 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results
6.33 Jul 27, 2017: Stryker reports second quarter 2017 results
6.34 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.35 Jul 20, 2017: SpinalCyte Receives New Japanese Patent
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Nucleus Replacement Devices - Pipeline Products by Stage of Development
Table 2: Nucleus Replacement Devices - Pipeline Products by Territory
Table 3: Nucleus Replacement Devices - Pipeline Products by Regulatory Path
Table 4: Nucleus Replacement Devices - Pipeline Products by Estimated Approval Date
Table 5: Nucleus Replacement Devices - Ongoing Clinical Trials
Table 6: Nucleus Replacement Devices Companies - Pipeline Products by Stage of Development
Table 7: Nucleus Replacement Devices - Pipeline Products by Stage of Development
Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NuReS - Product Status
Table 10: NuReS - Product Description
Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Chi2Disc - Product Status
Table 13: Chi2Disc - Product Description
Table 14: Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: NucleoFill - Product Status
Table 16: NucleoFill - Product Description
Table 17: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Biodisc Nucleus Pulposus Replacement - Product Status
Table 19: Biodisc Nucleus Pulposus Replacement - Product Description
Table 20: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Hydrafil - Product Status
Table 22: Hydrafil - Product Description
Table 23: Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: DiscCell - Product Status
Table 25: DiscCell - Product Description
Table 26: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Intervertebral Disc Repair System - Product Status
Table 28: Intervertebral Disc Repair System - Product Description
Table 29: Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Nucleus Pulposus Repair Device - Product Status
Table 31: Nucleus Pulposus Repair Device - Product Description
Table 32: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: HydraFlex Nucleus Arthroplasty System - Product Status
Table 34: HydraFlex Nucleus Arthroplasty System - Product Description
Table 35: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: NeuDisc - Product Status
Table 37: NeuDisc - Product Description
Table 38: Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: NuCore Injectable Nucleus - Product Status
Table 40: NuCore Injectable Nucleus - Product Description
Table 41: NuCore RPXL Injectable Nucleus - Product Status
Table 42: NuCore RPXL Injectable Nucleus - Product Description
Table 43: Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Aquarelle - Product Status
Table 45: Aquarelle - Product Description
Table 46: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Percutaneous Nucleus Replacement Implant - Product Status
Table 48: Percutaneous Nucleus Replacement Implant - Product Description
Table 49: Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: InterCushion Disc Nucleus Replacement System - Product Status
Table 51: InterCushion Disc Nucleus Replacement System - Product Description
Table 52: Vertebral Technologies Inc - Ongoing Clinical Trials Overview
Table 53: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy
Table 54: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Newcleus - Product Status
Table 56: Newcleus - Product Description
Table 57: Regain Lumbar Artificial Disc - Product Status
Table 58: Regain Lumbar Artificial Disc - Product Description
Table 59: Glossary
1.2 List of Figures
Figure 1: Nucleus Replacement Devices - Pipeline Products by Stage of Development
Figure 2: Nucleus Replacement Devices - Pipeline Products by Territory
Figure 3: Nucleus Replacement Devices - Pipeline Products by Regulatory Path
Figure 4: Nucleus Replacement Devices - Pipeline Products by Estimated Approval Date
Figure 5: Nucleus Replacement Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report